Pharma Foods International Co., Ltd. (TYO:2929)
537.00
+2.00 (0.37%)
Jun 19, 2026, 3:30 PM JST
TYO:2929 Revenue
Pharma Foods International had revenue of 16.11B JPY in the quarter ending April 30, 2026, a decrease of -4.99%. This brings the company's revenue in the last twelve months to 67.00B, up 8.42% year-over-year. In the fiscal year ending July 31, 2025, Pharma Foods International had annual revenue of 65.26B with 5.01% growth.
Revenue (ttm)
67.00B
Revenue Growth
+8.42%
P/S Ratio
0.23
Revenue / Employee
109.30M
Employees
613
Market Cap
15.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2025 | 65.26B | 3.11B | 5.01% |
| Jul 31, 2024 | 62.15B | -6.43B | -9.37% |
| Jul 31, 2023 | 68.57B | 8.39B | 13.94% |
| Jul 31, 2022 | 60.19B | 13.43B | 28.73% |
| Jul 31, 2021 | 46.75B | 31.40B | 204.51% |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 62.17B |
| Daito Pharmaceutical | 50.77B |
| Nippon Chemiphar | 33.09B |
| Koa Shoji Holdings | 23.98B |
| Morishita Jintan | 12.69B |
| Mizuho Medy | 10.82B |
| Wakamoto Pharmaceutical | 9.43B |
| Taiko Pharmaceutical | 6.16B |